Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6Urinary Bladder Neoplasms 1Hernia 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Alloderm × Clear all
NCT00956384 2024-12-05

AllodermRCT

University Health Network, Toronto

Phase NA Completed
198 enrolled 9 charts
Breast

Breast Neoplasms

NCT00639106 2018-10-03

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
70 enrolled
Breast

Breast Neoplasms

NCT02372305 2018-07-18

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

University of Arkansas

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT00872859 2017-05-18

The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial

University of Utah

Phase 4 Completed
128 enrolled
Breast

Breast Neoplasms

NCT01561287 2016-05-11

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

University of Kentucky

Phase 4 Completed
48 enrolled
Breast

Breast Neoplasms

NCT01027637 2013-09-06

Regenerative Tissue Matrix for Breast Reconstruction

Henry Ford Health System

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡